论文信息 - Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study. - 字舞流文

Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study.

J. Desai | J. Visvader | S. Dawson | D. Liew | A. Roberts | G. Lindeman | M. Rosenthal | S. Lok | K. Shackleton | B. Mann | A. Murugasu | A. Bergin | James R. Whittle | P. Sherman | J. Whittle